Bioventus LLC
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$9.5M
Doctors Paid
32,669
Transactions
75,291
2024 Total
$1.3M
Payment Breakdown by Category
Research$2.3M (24.2%)
Food & Beverage$2.1M (22.3%)
Consulting$1.8M (19.0%)
Travel$477,563 (5.0%)
Royalty/License$92,017 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.6M | 747 | 27.3% |
| Unspecified | $2.3M | 377 | 24.2% |
| Food and Beverage | $2.1M | 71,195 | 22.3% |
| Consulting Fee | $1.8M | 849 | 19.0% |
| Travel and Lodging | $477,563 | 1,996 | 5.0% |
| Royalty or License | $92,017 | 2 | 1.0% |
| Grant | $62,500 | 5 | 0.7% |
| Debt forgiveness | $36,306 | 20 | 0.4% |
| Education | $16,388 | 98 | 0.2% |
| Gift | $1,327 | 1 | 0.0% |
| Entertainment | $81.05 | 1 | 0.0% |
Payments by Type
General
$7.2M
74,914 transactions
Research
$2.3M
377 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Prospective, Open-Label, Dose-Escalation Phase 1 Study of Intra-Articular Administration of an Allogeneic Human Placental Tissue Particulate (PTP-001) for the Treatment of Knee Osteoarthritis | $492,411 | 3 | 29 |
| A Prospective, Randomized, Intra-Patient Controlled, Multi-Center Clinical Investigation evaluating OSTEOAMP SELECT Fibers versus Infuse Bone Graft as an autograft substitute in lumbar fusion procedures | $424,655 | 9 | 59 |
| A PROSPECTIVE, OPEN-LABEL,LONG-TERM, MULTI-CENTER, REGISTRY TO ASSESS THE SAFETY AND EFFICACY OF THE BIONESS STIMROUTER NEUROMODULATION SYSTEM IN SUBJECTS WITH CHRONIC PAIN OF PERIPHERAL NERVE ORIGIN | $191,655 | 9 | 31 |
| A Prospective, Multicenter Study of Instrumented Posterolateral Lumbar Fusions PLF with OsteoAMP to Evaluate Long-Term Safety and Efficacy in Patients Requiring 1-2 Level Instrumented PLF | $182,692 | 0 | 87 |
| Proposal to evaluate the biological activity of micronized placental tissue extract product | $162,800 | 0 | 3 |
| Proposal to evaluate the biological activity of micronized placental tissue extract (product) | $155,681 | 0 | 4 |
| PTP In Vivo Pilot Rabbit Study and Ex Vivo Retention Study | $139,930 | 0 | 3 |
| Agili-C Post Approval | $66,521 | 0 | 13 |
| Rat Rotator Cuff Injury & Repair Model Study | $60,848 | 0 | 3 |
| Use of SIGNAFUSE Bioactive Bone Graft Putty for Instrumented Posterolateral Spine Fusion A Retrospective Review with Prospective Follow-up Imaging | $42,400 | 0 | 7 |
| Bioventus Observational Non-interventional EXOGEN Studies | $39,650 | 1 | 10 |
| Agili-C Post-Approval | $37,545 | 0 | 5 |
| StimRouter Genicular Neuromodulation for Chronic Knee Osteoarthritic Pain Management (GLEAM Trial) | $36,936 | 1 | 1 |
| Proposal to determine the residence time of fluorescently-labelled PTP-001 in rat joints | $36,777 | 0 | 2 |
| Outcomes of Cadaveric Split-Thickness Skin Grafts in Wound Healing After Cutaneous Surgery | $35,350 | 1 | 1 |
| The effect of OsteoAMP use on recovery, arthrodesis, and quality of life gains in patients undergoing cervical and lumbar fusion | $30,000 | 1 | 2 |
| StimRouter Genicular Neuromodulation for Chronic Knee Osteoarthritic Pain Management | $25,561 | 0 | 2 |
| A Prospective, Randomized Study of Instrumented, Posterolateral Spinal Fusions with OsteoAMP versus Autograft | $22,604 | 2 | 26 |
| CartiHeal Post-Approval | $21,238 | 0 | 8 |
| MOTION REGISTRY: MOTYS Observational Time to-Event Initiative on Osteoarthritis in the kNee Registry | $17,200 | 0 | 59 |
| Use of OSTEOAMP in Lumbar Spine Fusion Surgery A Multi-CenterRetrospective Chart Review Including Independent Image Analysis | $14,550 | 0 | 3 |
| Effect of Low-Intensity Pulsed Ultrasound on Post-traumatic Osteoarthritis | $10,000 | 0 | 2 |
| A Prospective, Patient-centric, Observational, Consecutive Enrollment, Non-interventional Study of Patients At Risk for Fracture Non-union Treated With EXOGEN Compared to a National Healthcare Claims Database Control | $8,575 | 1 | 4 |
| Bioventus Observational Non-interventionalEXOGENStudies | $6,194 | 3 | 3 |
| MOTYS Observational Time to Event Initiative on Osteoarthritis in the Knee Registry | $5,425 | 1 | 3 |
| ADVANCE: ADVANcing the Clinical Evaluation of MOTYS | $4,726 | 0 | 1 |
| A Prospective, Open-label, Long-term, Multi-center, Registry to Assess the Safety and Efficacy of the Bioness StimRouter Neuromodulation System in Subjects with Chronic Pain of Peripheral Nerve Origin | $3,840 | 1 | 1 |
| Use of OSTEOAMP in Lumbar Spine Fusion Surgery: A Multi-Center Retrospective Chart Review Including Independent Image Analysis | $3,000 | 1 | 1 |
| Hypothesis that LIPUS treatment will rescue the diabetic fracture healing by restoring cilia formation and ciliary protein expression | $2,500 | 0 | 1 |
| A Prospective, Open-Label, Dose-Escalation Phase 1 Study of Intra Articular Administration of an Allogeneic Human Placental Tissue Particulate (PTP-001) for the Treatment of Knee Osteoarthritis | $1,300 | 1 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Vinod Dasa, M.d, M.D | Orthopaedic Surgery | Kenner, LA | $706,343 | $0 |
| Dr. Michael Redler, M.d, M.D | Sports Medicine | Trumbull, CT | $461,124 | $0 |
| Mr. Robert Zura, M.d, M.D | Orthopaedic Surgery | New Orleans, LA | $408,166 | $0 |
| Einar Ottestad, Md, MD | Pain Medicine | Stanford, CA | $129,120 | $0 |
| Shailesh Patel, Md, MD | Orthopaedic Surgery | North Charleston, SC | $113,232 | $0 |
| Dr. Sonya Ahmed, Md, MD | Orthopaedic Surgery | Pensacola, FL | $100,318 | $0 |
| Dr. K Brandon Strenge, Md, MD | Orthopaedic Surgery of the Spine | Paducah, KY | $97,153 | $0 |
| Peter Whang, Md, MD | Orthopaedic Surgery | New Haven, CT | $92,427 | $0 |
| Peter Blume, Dpmfacfas, DPMFACFAS | Podiatrist | New Haven, CT | $91,210 | $0 |
| Isador Lieberman, Md, MD | Orthopaedic Surgery | Plano, TX | $82,060 | $0 |
| Mark Campbell, Md, MD | Adult Reconstructive Orthopaedic Surgery | Sun City West, AZ | $76,396 | $0 |
| Stephen Mendelson, Md, MD | Orthopaedic Surgery | Sterling Heights, MI | $75,713 | $0 |
| Rakesh Patel, Md, MD | Orthopaedic Surgery of the Spine | Ann Arbor, MI | $74,009 | $0 |
| Dr. Thomas Chang, D.p.m, D.P.M | Foot & Ankle Surgery | Santa Rosa, CA | $73,433 | $0 |
| Dr. Khoi Than, Md, MD | Neurological Surgery | Durham, NC | $71,749 | $0 |
| Dr. Carmina Angeles, Md, MD | Neurological Surgery | Eugene, OR | $69,368 | $0 |
| Sam Nia, Md, MD | Pain Medicine | Worcester, MA | $69,246 | $0 |
| Raymond Hwang, Md, MD | Orthopaedic Surgery | Chestnut Hill, MA | $67,506 | $0 |
| Dr. Stanislav Tolkachjov, M.d, M.D | Dermatology | Lewisville, TX | $65,960 | $0 |
| Dr. Scott Daffner, M.d, M.D | Orthopaedic Surgery | Morgantown, WV | $63,238 | $0 |
| Dr. Meredith Warner, M.d, M.D | Orthopaedic Surgery | Baton Rouge, LA | $60,351 | $0 |
| Dr. Andrew Belis, Dpm, DPM | Foot & Ankle Surgery | Fort Myers, FL | $59,205 | $0 |
| Adam Crowl, Md, MD | Orthopaedic Surgery of the Spine | Richmond, VA | $56,486 | $0 |
| Dr. Howard An, Md, MD | Orthopaedic Surgery of the Spine | Chicago, IL | $55,202 | $0 |
| Dr. David Spinner, D.o, D.O | Pain Medicine | New York, NY | $52,251 | $0 |
Ad
Top Products
- Durolane $1.3M
- Exogen $1.1M
Associated Products (21)
- Durolane $1.3M
- Exogen $1.1M
- Stimrouter Implantable Kit $673,690
- OsteoAMP $611,364
- Exogen Ultrasound Bone Healing System $544,902
- EXOGEN ULTRASOUND BONE HEALING SYSTEM $505,646
- GELSYN 3 $282,454
- Bonescalpel $220,137
- DUROLANE $198,800
- BONESCALPEL & SONICONE (O.R.) $129,568
- AGILI-C $126,393
- STIMROUTER IMPLANTABLE KIT $111,593
- Nexus $97,295
- GELSYN-3 $79,502
- Signafuse Bioactive Bone Graft Putty $70,512
- SonicOne Clinic $36,839
- L360 Thigh System $32,064
- Supartz $21,479
- Theragenesis Bilayer Wound Matrix $14,692
- NEXUS-10 MKII $13,989
- Supartz FX Sodium Hyaluronate $12,229
Payment Categories
- Food & Beverage $2.1M
- Consulting $1.8M
- Travel & Lodging $477,563
- Research $2.3M
- Royalties $92,017
About Bioventus LLC
Bioventus LLC has made $9.5M in payments to 32,669 healthcare providers, recorded across 75,291 transactions in the CMS Open Payments database. In 2024, the company paid $1.3M. The top product by payment volume is Durolane ($1.3M).
Payments were distributed across 225 medical specialties. The top specialty by payment amount is Orthopaedic Surgery ($3.0M to 6,119 doctors).
Payment categories include: Food & Beverage ($2.1M), Consulting ($1.8M), Research ($2.3M), Travel & Lodging ($477,563), Royalties ($92,017).
Bioventus LLC is associated with 21 products in the CMS Open Payments database, including Durolane, Exogen, and Stimrouter Implantable Kit.